These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20110565)

  • 1. Safety pharmacology and genotoxicity evaluation of AVI-4658.
    Sazani P; Weller DL; Shrewsbury SB
    Int J Toxicol; 2010; 29(2):143-56. PubMed ID: 20110565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical and mechanistic toxicology evaluation of exon skipping phosphorodiamidate morpholino oligomers in mdx mice.
    Sazani P; Ness KP; Weller DL; Poage D; Nelson K; Shrewsbury AS
    Int J Toxicol; 2011 May; 30(3):322-33. PubMed ID: 21540335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat-dose toxicology evaluation in cynomolgus monkeys of AVI-4658, a phosphorodiamidate morpholino oligomer (PMO) drug for the treatment of duchenne muscular dystrophy.
    Sazani P; Ness KP; Weller DL; Poage DW; Palyada K; Shrewsbury SB
    Int J Toxicol; 2011 May; 30(3):313-21. PubMed ID: 21540336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicological Characterization of Exon Skipping Phosphorodiamidate Morpholino Oligomers (PMOs) in Non-human Primates.
    Carver MP; Charleston JS; Shanks C; Zhang J; Mense M; Sharma AK; Kaur H; Sazani P
    J Neuromuscul Dis; 2016 Aug; 3(3):381-393. PubMed ID: 27854228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice.
    Negishi Y; Ishii Y; Shiono H; Akiyama S; Sekine S; Kojima T; Mayama S; Kikuchi T; Hamano N; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
    Mol Pharm; 2014 Mar; 11(3):1053-61. PubMed ID: 24433046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosing regimen has a significant impact on the efficiency of morpholino oligomer-induced exon skipping in mdx mice.
    Malerba A; Thorogood FC; Dickson G; Graham IR
    Hum Gene Ther; 2009 Sep; 20(9):955-65. PubMed ID: 19469709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.
    McClorey G; Moulton HM; Iversen PL; Fletcher S; Wilton SD
    Gene Ther; 2006 Oct; 13(19):1373-81. PubMed ID: 16724091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
    Heemskerk HA; de Winter CL; de Kimpe SJ; van Kuik-Romeijn P; Heuvelmans N; Platenburg GJ; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
    J Gene Med; 2009 Mar; 11(3):257-66. PubMed ID: 19140108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomers.
    Popplewell LJ; Malerba A; Dickson G
    Methods Mol Biol; 2012; 867():143-67. PubMed ID: 22454060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping.
    Mitrpant C; Fletcher S; Iversen PL; Wilton SD
    J Gene Med; 2009 Jan; 11(1):46-56. PubMed ID: 19006096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides.
    Echigoya Y; Yokota T
    Nucleic Acid Ther; 2014 Feb; 24(1):57-68. PubMed ID: 24380394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Human Pharmacokinetics of Phosphorodiamidate Morpholino Oligonucleotides in Duchenne Muscular Dystrophy Patients Using Viltolarsen.
    Imai S; Suda Y; Mori J; Sasaki Y; Yamada T; Kusano K
    Drug Metab Dispos; 2023 Oct; 51(10):1428-1435. PubMed ID: 37468285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exon-skipping events in candidates for clinical trials of morpholino.
    Nakano S; Ozasa S; Yoshioka K; Fujii I; Mitsui K; Nomura K; Kosuge H; Endo F; Matsukura M; Kimura S
    Pediatr Int; 2011 Aug; 53(4):524-9. PubMed ID: 21342350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers.
    Moulton HM
    Methods Mol Biol; 2012; 867():407-14. PubMed ID: 22454076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic and functional optimization of antisense phosphorodiamidate morpholino oligomers (PMOs) for therapeutic modulation of RNA splicing in muscle.
    Popplewell LJ; Graham IR; Malerba A; Dickson G
    Methods Mol Biol; 2011; 709():153-78. PubMed ID: 21194027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrity.
    Malerba A; Boldrin L; Dickson G
    Nucleic Acid Ther; 2011 Aug; 21(4):293-8. PubMed ID: 21851223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exon-skipping therapy for Duchenne muscular dystrophy.
    Nakamura A; Takeda S
    Neuropathology; 2009 Aug; 29(4):494-501. PubMed ID: 19486303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the potential genotoxicity of pure capsaicin in bacterial mutation, chromosome aberration, and rodent micronucleus tests.
    Proudlock R; Thompson C; Longstaff E
    Environ Mol Mutagen; 2004; 44(5):441-7. PubMed ID: 15517568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vinyl laurate in a battery of in vitro and in vivo tests for genotoxicity.
    van Acker F; Messinger H; Bär A
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):77-84. PubMed ID: 25445001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells.
    Aartsma-Rus A; Kaman WE; Bremmer-Bout M; Janson AA; den Dunnen JT; van Ommen GJ; van Deutekom JC
    Gene Ther; 2004 Sep; 11(18):1391-8. PubMed ID: 15229633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.